Wegovy Approved for Major Heart Disease Prevention

(MedPage Today) -- The FDA approved semaglutide (Wegovy) to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight, the agency announced on Friday. A GLP-1 receptor...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news